HU9601786D0 - Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis - Google Patents
Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosisInfo
- Publication number
- HU9601786D0 HU9601786D0 HU9601786A HU9601786A HU9601786D0 HU 9601786 D0 HU9601786 D0 HU 9601786D0 HU 9601786 A HU9601786 A HU 9601786A HU 9601786 A HU9601786 A HU 9601786A HU 9601786 D0 HU9601786 D0 HU 9601786D0
- Authority
- HU
- Hungary
- Prior art keywords
- diaryl
- osteoporosis
- medicament
- prevention
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/175,899 US5389646A (en) | 1993-12-30 | 1993-12-30 | Methods for treatment and prevention of bone loss using 2,3-benzopyrans |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9601786D0 true HU9601786D0 (en) | 1996-09-30 |
HUT75705A HUT75705A (en) | 1997-05-28 |
Family
ID=22642125
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9601786A HUT75705A (en) | 1993-12-30 | 1994-12-14 | Processes for the manufacture of a medicament in the treatment and prevention of bone loss |
Country Status (11)
Country | Link |
---|---|
US (1) | US5389646A (hu) |
KR (1) | KR100213963B1 (hu) |
CN (1) | CN1142767A (hu) |
AU (1) | AU701411B2 (hu) |
CA (1) | CA2180178C (hu) |
CZ (1) | CZ192396A3 (hu) |
FI (1) | FI962685A (hu) |
HU (1) | HUT75705A (hu) |
NO (1) | NO962752L (hu) |
RU (1) | RU2166316C2 (hu) |
WO (1) | WO1995017892A1 (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5407955A (en) * | 1994-02-18 | 1995-04-18 | Eli Lilly And Company | Methods for lowering serum cholesterol and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease |
US5637598A (en) * | 1994-11-18 | 1997-06-10 | Eli Lilly And Company | Methods of inhibiting bone loss |
WO1997048694A1 (en) * | 1996-06-20 | 1997-12-24 | Board Of Regents, The University Of Texas System | Compounds and methods for providing pharmacologically active preparations and uses thereof |
US6043269A (en) * | 1996-10-28 | 2000-03-28 | Novo Nordisk A/S | cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes |
US7005428B1 (en) | 1998-06-11 | 2006-02-28 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
US6465445B1 (en) * | 1998-06-11 | 2002-10-15 | Endorecherche, Inc. | Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors |
MX2007003216A (es) | 2004-09-21 | 2008-03-10 | Novogen Res Pty Ltd | Derivados y medicamentos sustituidos del cromano y su uso en terapias. |
US8080675B2 (en) * | 2004-09-21 | 2011-12-20 | Marshall Edwards, Inc. | Chroman derivatives, medicaments and use in therapy |
EA022551B1 (ru) | 2010-06-10 | 2016-01-29 | Серагон Фармасьютикалс, Инк. | Модуляторы рецепторов эстрогена и их применение |
US9663484B2 (en) | 2010-11-01 | 2017-05-30 | Mei Pharma, Inc. | Isoflavonoid compounds and methods for the treatment of cancer |
JP2015500346A (ja) | 2011-12-14 | 2015-01-05 | セラゴン ファーマシューティカルズ,インク. | エストロゲン受容体モジュレーターおよびその使用 |
PT3253208T (pt) | 2015-02-02 | 2021-06-17 | The Spanish National Cancer Res Centre | Terapêuticas de combinação para utilização no tratamento do cancro da mama |
CN104926776B (zh) * | 2015-07-06 | 2018-05-25 | 江南大学 | 4-苯甲酰亚甲基黄烷类衍生物的绿色合成方法 |
SG11201803119XA (en) | 2015-10-27 | 2018-05-30 | Sun Pharma Advanced Res Co Ltd | Novel heterocyclic antiestrogens |
BR112022001285A2 (pt) | 2019-07-22 | 2022-03-22 | Sun Pharma Advanced Res Co Ltd | Degradador seletivo do receptor de estrogênio |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE1518002C3 (de) * | 1965-01-02 | 1975-01-23 | Merck Patent Gmbh, 6100 Darmstadt | Isoflavane und Isoflavene und Verfahren zu Ihrer Herstellung sowie diese enthaltende Arzneimittel |
US4210644A (en) * | 1978-02-23 | 1980-07-01 | The Johns Hopkins University | Male contraception |
US4489056A (en) * | 1982-06-30 | 1984-12-18 | Merck & Co., Inc. | Acid anhydrides as rate controlling agent for the erosion of polymers which latter polymers have beneficial substances dispersed throughout their matrix or where the polymer matrix surrounds the beneficial substance |
JPS60132976A (ja) * | 1983-12-21 | 1985-07-16 | Takeda Chem Ind Ltd | 新規3−フエニル−4h−1−ベンゾピラン−4−オン誘導体 |
US4644012A (en) * | 1983-12-21 | 1987-02-17 | Takeda Chemical Industries, Ltd. | Treatment for osteoporosis |
US5254568A (en) * | 1990-08-09 | 1993-10-19 | Council Of Scientific & Industrial Research | Benzopyrans as antiestrogenic agents |
JP3502403B2 (ja) * | 1991-12-16 | 2004-03-02 | アベンティス ファーマ株式会社 | 骨吸収抑制剤 |
US5280040A (en) * | 1993-03-11 | 1994-01-18 | Zymogenetics, Inc. | Methods for reducing bone loss using centchroman derivatives |
-
1993
- 1993-12-30 US US08/175,899 patent/US5389646A/en not_active Expired - Fee Related
-
1994
- 1994-12-14 CZ CZ961923A patent/CZ192396A3/cs unknown
- 1994-12-14 WO PCT/US1994/014568 patent/WO1995017892A1/en not_active Application Discontinuation
- 1994-12-14 AU AU14039/95A patent/AU701411B2/en not_active Ceased
- 1994-12-14 CA CA002180178A patent/CA2180178C/en not_active Expired - Fee Related
- 1994-12-14 HU HU9601786A patent/HUT75705A/hu unknown
- 1994-12-14 RU RU96115938/14A patent/RU2166316C2/ru not_active IP Right Cessation
- 1994-12-14 CN CN94194925A patent/CN1142767A/zh active Pending
-
1996
- 1996-06-28 NO NO962752A patent/NO962752L/no not_active Application Discontinuation
- 1996-06-28 FI FI962685A patent/FI962685A/fi unknown
- 1996-06-29 KR KR1019960703521A patent/KR100213963B1/ko not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR100213963B1 (en) | 1999-08-02 |
AU701411B2 (en) | 1999-01-28 |
HUT75705A (en) | 1997-05-28 |
CA2180178C (en) | 2001-03-20 |
FI962685A (fi) | 1996-08-28 |
NO962752D0 (no) | 1996-06-28 |
RU2166316C2 (ru) | 2001-05-10 |
CZ192396A3 (en) | 1997-03-12 |
US5389646A (en) | 1995-02-14 |
FI962685A0 (fi) | 1996-06-28 |
NO962752L (no) | 1996-08-29 |
WO1995017892A1 (en) | 1995-07-06 |
CA2180178A1 (en) | 1995-07-06 |
AU1403995A (en) | 1995-07-17 |
CN1142767A (zh) | 1997-02-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1011926A1 (en) | The use of bisphosphonates in bone surgery | |
GB9415125D0 (en) | Surgical product and its use | |
IL127714A0 (en) | Use of topiramate or derivatives thereof for the manufacture of a medicament for the treatment of manic depressive bipolar disorders | |
GB9419974D0 (en) | Modular orthopedic brace | |
IL119894A (en) | Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis | |
GB2279879B (en) | Medicament inhalers | |
GB8900678D0 (en) | Compositions for the prevention and medical treatment of parodonthopathy | |
KR100213963B1 (en) | Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis | |
GB9213008D0 (en) | Knee surgery | |
HK1022269A1 (en) | Use of 1-hydroxy-2-pyridones in the manufacture of a medicament for treating skin infections | |
IL116142A0 (en) | Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis | |
AP9400676A0 (en) | Process for the preparation of n-methyl-3-(1-methyl-4-piperidinyl)-1h-indole-5-ethanesulphonamid-e and physiologically acceptable salts thereof | |
HU9400290D0 (en) | Pharmaceutical composition for preventing and treating retinal dieases | |
IL115224A0 (en) | Preparations for use in the treatment of osteoporosis | |
HUP9802736A3 (en) | Use of 1,4-dihydropyridine derivatives for the preparation of medicament for the prevention and therapy of atherosclerotic degradation in the arterial walls | |
GB9217124D0 (en) | Medical treatment | |
ZA944187B (en) | Ipsapirone medicament formulation | |
HK44597A (en) | Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration | |
GB9408084D0 (en) | Medical treatment | |
IL130103A0 (en) | The use of a diarylalkane derivative in the manufacture of a medicament for treatment or prevention of pancreatitis | |
GB9321793D0 (en) | Medical treatment | |
PL54844Y1 (en) | Dental surgeon's syringe | |
EG19885A (en) | Medicament for the treatment of hyperlipidaemia and/or atherosolerosis | |
GB9314075D0 (en) | Orthopaedic splinting materials | |
GB9314074D0 (en) | Orthopaedic splinting materials |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFC4 | Cancellation of temporary protection due to refusal |